openPR Logo
Press release

Global Type 2 Diabetes Drugs Market to grow at a CAGR of 7.28% during the period 2017-2020

05-16-2017 03:54 PM CET | Health & Medicine

Press release from: Diabetes Drugs

ALBANY, NY, May 16, 2017 : Diabetes, often referred to as diabetes mellitus, is a metabolic disease in which the patients' blood glucose levels remains high. Depending on the cause of development of diabetes, it can be divided into three types:
Type 1 diabetes (or insulin-dependent diabetes mellitus): In this condition, the pancreas do not produce the required amount of insulin, leading to high blood glucose levels.

Type 2 diabetes (non-insulin dependent diabetes mellitus): In this condition, though the body produces the required amount of insulin, the cells do not respond to it, increasing the glucose levels in the body.
Gestational diabetes: This condition occurs in pregnant women without any prior history of diabetes
Type 2 diabetes, also known as adult-onset diabetes, is a result of the body's inability to produce enough insulin or insulin resistance or both. It is managed by providing symptomatic relief and improving the quality of life. Type 2 diabetes accounts for nearly 90%-95% of the total number of diabetes cases worldwide and is primarily diagnosed in the middle-aged and old age groups, i.e., between the ages of 30 and 75 years. However, it can occur even during childhood. The risks of type 2 diabetes include high blood pressure, advancing age, obesity, history of gestational diabetes, family history of diabetes, poor nutrition during pregnancy, physical inactivity, and impaired glucose tolerance.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=685249

Technavios analysts forecast the global type 2 diabetes drugs market to grow at a CAGR of 7.28% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global type 2 diabetes drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat type 2 diabetes.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Type 2 Diabetes Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AstraZeneca plc
Eli Lilly and Company
Merck & Co. Inc.
Novo Nordisk A/S
Sanofi SA

Other prominent vendors
Adocia
Akros Pharma
Amgen
Astellas Pharma
Biocon
Boehringer Ingelheim
Chipscreen Biosciences
ConjuChem
CymaBay Therapeutics
Daiichi Sankyo
DiaMedica
Diasome Pharmaceuticals
Dong-A ST
Elcelyx Therapeutics
Exsulin
Generex
Genfit
Hanmi
Hua Medicine
InteKrin Therapeutics
Ionis Pharmaceuticals
Janssen Pharmaceuticals
Japan Tobacco
Kadmon
KinDex Pharmaceuticals
Kissei
Kotobuki Pharmaceutical
Lexicon Pharmaceuticals
Ligand
MannKind
MedImmune
Melior Pharmaceuticals
Metabolic Solutions Development Company
Mitsubishi Tanabe Pharma
Novartis
NGM Bio
NuSirt Biopharma
Oramed
Peptron
Pfizer
PhaseBio
Poxel
Sanwa Kagaku Kenkyusho
Sirona Biochem
Takeda
Theracos
Theratechnologies
Transition Therapeutics
VeroScience
vTv Therapeutics
XBiotech

Market driver
Rising prevalence of diabetes
For a full, detailed list, view our report

Market challenge
Low diagnosis rate
For a full, detailed list, view our report

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=685249

Market trend
Increase in awareness of diabetes
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
90 State Street,
Albany, NY 12207,
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Type 2 Diabetes Drugs Market to grow at a CAGR of 7.28% during the period 2017-2020 here

News-ID: 538771 • Views:

More Releases from Diabetes Drugs

Global Diabetes Drugs Market Report 2019 Companies included Novo Nordisk(US), Sanofi(DE), Merck, Eli Lilly(UK), AstraZeneca, Boehringer Ingelheim and Others
Global Diabetes Drugs Market Report 2019 Companies included Novo Nordisk(US), Sa …
Market Reports Company has recently published 7th edition of Diabetes Drugs Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Diabetes Drugs market was valued at
Diabetes Drugs Market: Global Analysis, Opportunities and Forecast To 2023
Diabetes Drugs Market: Global Analysis, Opportunities and Forecast To 2023
Researchmoz added Most up-to-date research on "Diabetes Drugs Market: Global Analysis, Opportunities and Forecast To 2023" to its huge collection of research reports. Diabetes Drugs Market This report provides insight into the diversifying and highly lucrative diabetes mellitus (DM) market. Analysis has identified a high level of diversification in the market, which is of vital importance for investors and key market players. Furthermore, the report provides insight into groundbreaking drugs, and the
Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes
Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP …
Researchmoz added Most up-to-date research on "Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes" to its huge collection of research reports. Global Diabetes Drugs Market This report provides insight into the diversifying and highly lucrative diabetes mellitus (DM) market. Analysis has identified a high level of diversification in the market, which is of vital importance for

All 4 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the